Compare Relay Therapeutics Inc. Common Stock (RLAY) vs SentinelOne Inc. Class A Common Stock (S) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Relay Therapeutics Inc. Common Stock vs SentinelOne Inc. Class A Common Stock — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.84 (market cap $3.82B), while SentinelOne Inc. Class A Common Stock trades at $26.27 (market cap $8.84B). The key difference: SentinelOne Inc. Class A Common Stock is far larger — about 2.3× Relay Therapeutics Inc. Common Stock's market cap, and SentinelOne Inc. Class A Common Stock is trading nearer its 52-week high, Relay Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and SentinelOne Inc. Class A Common Stock for 0 Days on average.
| RLAY | S | |
|---|---|---|
Market Cap | $3.82B | $8.84B |
Volume | 4,332,079 | 7,515,091 |
Sector | Health | Technology |
52-Week High | $20.75 | $25.80 |
52-Week Low | $6.03 | $11.94 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.93B | $8.23B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →About SentinelOne Inc. Class A Common Stock
SentinelOne provides an AI-powered cybersecurity platform for organizations. Its Singularity platform helps detect, prevent, and respond to threats across endpoints, cloud workloads, identities, and connected devices.
Read more on S →
